I read with great interest the article by Do et al. on the clinical characteristics of older-onset versus common-age-of-onset gout. The authors provide valuable insights into how age at onset influences comorbidities, treatment strategies, and disease expression. I would like to add a perspective on two important aspects that merit further discussion: the role of older women and the potential impact of hormonal therapy during menopause.
Mattioli, A.V. (2025). Menopause, Hormone Therapy, and Gout in Older Women: An Overlooked Connection : A Comment on "Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study" by Do et al. DRUGS & AGING, 42, 1201-1202 [10.1007/s40266-025-01262-w].
Menopause, Hormone Therapy, and Gout in Older Women: An Overlooked Connection : A Comment on "Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study" by Do et al
Mattioli, Anna Vittoria
Primo
Conceptualization
2025
Abstract
I read with great interest the article by Do et al. on the clinical characteristics of older-onset versus common-age-of-onset gout. The authors provide valuable insights into how age at onset influences comorbidities, treatment strategies, and disease expression. I would like to add a perspective on two important aspects that merit further discussion: the role of older women and the potential impact of hormonal therapy during menopause.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



